Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial
Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an error notice. This indicates restricted access to the trial information that users expect on this page.SummaryDifference17%

- Check19 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a backend or documentation update behind the page while the study details remain unchanged.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6. No study content or data on the page appears to have changed.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5. This reflects a maintenance update to the page.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing v3.6.3. This indicates a minor update to the page's documentation/versioning rather than changes to the study content.SummaryDifference0.0%

- Check90 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, indicating a new version of the document. The update records the revision change in the page metadata.SummaryDifference0.0%

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.